These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8384406

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [Abstract] [Full Text] [Related]

  • 44. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE, Mosquera JM, Leykauf K, Gattuso P, Dürst M, Alonso A.
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [Abstract] [Full Text] [Related]

  • 45. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
    Mylona EE, Alexandrou PT, Giannopoulou IA, Rafailidis PI, Markaki S, Keramopoulos A, Nakopoulou LL.
    Cancer Detect Prev; 2006 May; 30(2):111-7. PubMed ID: 16632244
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L, Chhieng DC, Bell WC, Grizzle WE, Frost AR.
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [Abstract] [Full Text] [Related]

  • 48. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
    Kwaepila N, Burns G, Leong AS.
    Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
    [Abstract] [Full Text] [Related]

  • 49. Immunoreactive opioid peptides in human breast cancer.
    Scopsi L, Balslev E, Brünner N, Poulsen HS, Andersen J, Rank F, Larsson LI.
    Am J Pathol; 1989 Feb; 134(2):473-9. PubMed ID: 2464945
    [Abstract] [Full Text] [Related]

  • 50. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.
    Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M.
    Am J Pathol; 1990 Jan; 136(1):219-27. PubMed ID: 2153347
    [Abstract] [Full Text] [Related]

  • 51. Vimentin expression in different types of breast carcinoma immunohistochemical study.
    Essa TM, el Tatawi FA, Hamdi KN, Arafa WA.
    J Egypt Soc Parasitol; 1996 Aug; 26(2):433-42. PubMed ID: 8754651
    [Abstract] [Full Text] [Related]

  • 52. p53 protein expression and nuclear DNA content in breast intraductal proliferations.
    Schmitt FC, Leal C, Lopes C.
    J Pathol; 1995 Jul; 176(3):233-41. PubMed ID: 7674086
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.
    Zhang SY, Ruggeri B, Agarwal P, Sorling AF, Obara T, Ura H, Namiki M, Klein-Szanto AJ.
    Arch Pathol Lab Med; 1994 Feb; 118(2):150-4. PubMed ID: 8311654
    [Abstract] [Full Text] [Related]

  • 56. Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?
    Paredes J, Milanezi F, Reis-Filho JS, Leitão D, Athanazio D, Schmitt F.
    Pathol Res Pract; 2002 Feb; 198(12):795-801. PubMed ID: 12608656
    [Abstract] [Full Text] [Related]

  • 57. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
    Bedner E, Harezga B, Osborn M, Domagała W.
    Pol J Pathol; 1995 Feb; 46(1):11-5. PubMed ID: 7780691
    [Abstract] [Full Text] [Related]

  • 58. Ultrastructure of medullary, intraductal, tubular and adenocystic breast carcinomas: comparative patterns of myoepithelial differentiation and basal lamina deposition.
    Gould VE, Miller J, Jao W.
    Am J Pathol; 1975 Mar; 78(3):401-8. PubMed ID: 164121
    [Abstract] [Full Text] [Related]

  • 59. [Histological grading of ductal pancreatic carcinomas. Relationship to silver staining of NOR-associated proteins and to p53 immunoreactivity].
    Reich O, Heinisch G, Justus J.
    Zentralbl Pathol; 1994 Mar; 140(1):49-54. PubMed ID: 7515673
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.